Apyx Medical CorporationAPYXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank79
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-10.96%
↑ 74% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-42.00%
Historical baseline
PeriodValueYoY Change
2025-10.96%+68.6%
2024-34.93%-1.0%
2023-34.60%+30.0%
2022-49.44%-72.5%
2021-28.66%+57.0%
2020-66.67%+1.3%
2019-67.55%+19.0%
2018-83.41%-149.4%
2017-33.45%-223.1%
2016-10.35%-